Patent US5093271A successfully refreshed from Google Patents.
US5093271A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for the quantitative determination of antigens and antibodies by ratio of absorbances at different wavelengths
Assignee: Shimadzu Corp
•
Filing: 1987-11-24
•
Granted: 1992-03-03
•
Expires: 2007-11-24
Abstract
Abstract A method for the quantitative determination of antigen (or antibody) which comprises adding a sample containing an antigen (or antibody) to a dispersion of an insoluble carrier of fine particle size with an antibody (or antigen) fixed thereto to effect an antigen-antibody reaction, measuring absorbance of the reaction mixture, Aλ 1 and Aλ 2 , at two different wavelengths, λ 1 and λ 2 , and calculating the concentration of said antigen (or antibody) in the sample from the absorbance ratio Aλ 1 /Aλ 2 . This method is suitable for the measurment of the amount of an antigen or antibody in samples taken from living bodies using a simple procedure which has high sensitivity.
Inventors
- 👤 Hideki Yamamoto
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 13:13
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/543; G01N33/54313; G01N33/68; Y; Y10; Y10S; Y10S435/00; Y10S435/808
Claims Analysis
Total Claims: 18
Claim 1
Independent Claim
198 words
A method for determining the concentration of an antigen in a sample, comprising: (a) adding the sample to a test dispersion of a finely divided carrier having an antibody affixed thereto in a dispersing medium in which the carrier is insoluble, to produce an antigen-antibody reaction therebetween; (b) reacting the sample antigen with the carrier antibody for a predetermined reaction period; (c) measuring the absorbance (A) of the test dispersion after the reaction period at a first wavelength (λ 1 ) to determine a first absorbance value (Aλ 1 ), and measuring the absorbance (A) of the test dispersion after the reaction period at a second wavelength (λ 2 ) to determine a second absorbance value Aλ 2 ); (d) determining the absorbance ratio (Aλ 1 /Aλ 2 ) of the first absorbance value (Aλ 1 ) and the second absorbance value (Aλ 2 ) of the test dispersion; and (e) determining the concentration of the sample antigen by comparing the absorbance ratio of the test dispersion (Aλ 1 /Aλ 2 ) to reference absorbance ratios at said wavelengths of reference dispersions of said carrier having said antibody affixed thereto and reacted with pre-selected concentrations of said antigen.
Claim 2
Independent Claim
198 words
A method for determining the concentration of an antigen in a sample, comprising: (a) adding the sample to a test dispersion of a finely divided carrier having an antibody affixed thereto in a dispersing medium in which the carrier is insoluble, to produce an antigen-antibody reaction therebetween; (b) reacting the sample antigen with the carrier antibody for a predetermined reaction period; (c) measuring the absorbance (A) of the test dispersion after the reaction period at a first wavelength (λ 1 ) to determine a first absorbance value (Aλ 1 ), and measuring the absorbance (A) of the test dispersion after the reaction period at a second wavelength (λ 2 ) to determine a second absorbance value Aλ 2 ); (d) determining the absorbance ratio (Aλ 1 /Aλ 2 ) of the first absorbance value (Aλ 1 ) and the second absorbance value (Aλ 2 ) of the test dispersion; and (e) determining the concentration of the sample antigen by comparing the absorbance ratio of the test dispersion (Aλ 1 /Aλ 2 ) to reference absorbance ratios at said wavelengths of reference dispersions of said carrier having said antibody affixed thereto and reacted with pre-selected concentrations of said antigen.
Claim 3
Dependent Claim
122 words
The method as defined in claim 1, wherein the absorbance ratio of the test dispersion is comapred with the absorbance ratios of the reference dispersions in step (e) by: (1) measuring the reference absorbances of a plurality of the reference dispersions containing said pre-selected concentrations of said antigen after said reaction period at each of said wavelengths λ 1 and λ 1 ; (2) determining the reference absorbance ratios of the respective reference dispersions at said first and second wavelengths; (3) correlating said reference absorbance ratios to the concentrations of said antigen in said reference dispersions; and (4) comparing the absorbance ratio of the test dispersion with said correlated reference absorbance ratios to determine the concentration of antigen in the test dispersion.
Claim 4
Dependent Claim
21 words
The method as defined in claim 1, wherein the carrier has a median particle diameter of from 0.05 to 1.0 μm.
Claim 5
Dependent Claim
21 words
The method as defined in claim 1, wherein the carrier has a median particle diameter of from 0.1 to 0.2 μm.
Claim 6
Dependent Claim
38 words
The method as defined in claim 1, wherein the concentration of carrier in dispersing medium in step (a) is from 1 to 100 mg/l, and the predetermined reaction period of step (b) is from 0.5 to 2 hours.
Claim 7
Dependent Claim
41 words
The method as defined in claim 1, wherein the first wavelength (λ 1 ) of step (c) is from 330 nm to 1000 nm, and the second wavelength (λ 2 ) of step (c) is from 330 nm to 1000 nm.
Claim 8
Dependent Claim
37 words
The method as defined in claim 1, wherein the first wavelength (λ 1 ) and the second wavelength (λ 2 ) of step (c) have a difference in the range of from 300 nm to 600 nm.
Claim 9
Dependent Claim
55 words
The method as defined in claim 1, wherein the antigen in the sample is selected from the group consisting of albumin ferritin, alpha fetoprotein (AFP), β 2 -mciroglobulin, mioglobin, C-reactive protein (CRP), anti-streptolysin-O (ASO), Rheumatoid Factor (RF), fibrin degradation products (FDP), human chronic gonadotropin (hCG), human placental lactogen (hPL), carcino-embryonil antigen (CEA), fibrinogen and gonadotropin.
Claim 10
Independent Claim
193 words
A method for determining the concentration of an antibody in a sample, comprising: (a) adding the sample to a test dispersion of a finely divided carrier having an antigen affixed thereto in a dispersing medium in which the carrier is insoluble, to produce an antibody-antigen reaction therebetween; (b) reacting the sample antibody with the carrier antigen for a predetermined reaction period; (c) measuring the absorbance (A) of the test dispersion after the reaction period at a first wavelength (λ 1 ) to determine a first absorbance value (Aλ 1 ), and measuring the absorbance (A) of the test dispersion after the reaction period at a second wavelength (λ 2 ) to determine a second absorbance value (Aλ 2 ); (d) determining the absorbance ratio of the first absorbance value (Aλ 1 ) and the second absorbance value (Aλ 2 ) of the test dispersion; and (e) determining the concentration of the sample antibody by comparing the absorbance ratio of the test dispersion (Aλ 1 /Aλ 2 ) to reference absorbance ratios at said wavelengths of reference dispersions of said carrier having said antigen affixed thereto and reacted with pre-selected concentrations of said antibody.
Claim 11
Independent Claim
193 words
A method for determining the concentration of an antibody in a sample, comprising: (a) adding the sample to a test dispersion of a finely divided carrier having an antigen affixed thereto in a dispersing medium in which the carrier is insoluble, to produce an antibody-antigen reaction therebetween; (b) reacting the sample antibody with the carrier antigen for a predetermined reaction period; (c) measuring the absorbance (A) of the test dispersion after the reaction period at a first wavelength (λ 1 ) to determine a first absorbance value (Aλ 1 ), and measuring the absorbance (A) of the test dispersion after the reaction period at a second wavelength (λ 2 ) to determine a second absorbance value (Aλ 2 ); (d) determining the absorbance ratio of the first absorbance value (Aλ 1 ) and the second absorbance value (Aλ 2 ) of the test dispersion; and (e) determining the concentration of the sample antibody by comparing the absorbance ratio of the test dispersion (Aλ 1 /Aλ 2 ) to reference absorbance ratios at said wavelengths of reference dispersions of said carrier having said antigen affixed thereto and reacted with pre-selected concentrations of said antibody.
Claim 12
Dependent Claim
122 words
The method as defined in claim 1, wherein the absorbance ratio of the test dispersion is compared with the absorbance ratios of the reference dispersion in step (e) by: (1) measuring the reference absorbances of a plurality of the reference dispersions containing said pre-selected concentrations of said antigen after said reaction period at each of said wavelengths λ 1 and λ 1 ; (2) determining the reference absorbance ratios of the respective reference dispersions at said first and second wavelengths; (3) correlating said reference absorbance ratios to the concentrations of said antigen in said reference dispersions; and (4) comparing the absorbance ratio of the test dispersion with said correlated reference absorbance ratios to determine the concentration of antigen in the test dispersion.
Claim 13
Dependent Claim
21 words
The method as defined in claim 9, wherein the carrier has a median particle diameter of from 0.05 to 1.0 μm.
Claim 14
Dependent Claim
21 words
The method as defined in claim 9, wherein the carrier has a median particle diameter of from 0.1 to 0.2 μm.
Claim 15
Dependent Claim
38 words
The method as defined in claim 9, wherein the concentration of carrier in dispersing medium in step (a) is from 1 to 100 mg/l, and the predetermined reaction period of step (b) is from 0.5 to 2 hours.
Claim 16
Dependent Claim
41 words
The method as defined in claim 9, wherein the first wavelength (λ 1 ) of step (c) is from 330 nm to 1000 nm, and the second wavelength (λ 2 ) of step (c) is from 330 nm to 1000 nm.
Claim 17
Dependent Claim
37 words
The method as defined in claim 9, wherein the first wavelength (λ 1 ) and the second wavelength (λ 2 ) of step (c) have a difference in the range of from 300 nm to 600 nm.
Claim 18
Dependent Claim
32 words
The method as defined in claim 9, wherein the antibody in the sample is selected from the group consisting of immunoglobulin A, immunoglobulin E, immunoglobulin D, immunoglobulin G, immunoglobulin M and γ-globulin.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-03-03 | 1995-09-02 | 1996-03-03 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-03-03 | 1999-09-02 | 2000-03-03 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-03-03 | 2003-09-02 | 2004-03-03 | $7700.00 | Window Closed / Lapsed |